Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma

.

Source: Expert Opinion on Biological Therapy - May 24, 2023 Category: Drugs & Pharmacology Authors: Hanna Kose ła-Paterczyk Piotr Rutkowski Source Type: research